The Rhino robot mower design is a direct response to valuable insights gathered from our user community. The chosen product name, Rhino, brings our creation to life, fostering a deep emotional connection with our audience. The naming process began in March 2023, spanning six months to…
Month: January 2024
Freedom Financial Holdings Announces Earnings for Fourth Quarter and Full Year 2023
FAIRFAX, Va., Jan. 26, 2024 /PRNewswire/ — Freedom Financial Holdings (OTCQX: FDVA), (the “Company” or “Freedom”), the holding company for The Freedom Bank of Virginia (the “Bank”) today announced a net loss of $2,006,393, or -$0.27 per diluted share for the three months ended December…
Freedom Financial Holdings Announces Earnings for Fourth Quarter and Full Year 2023
FAIRFAX, Va., Jan. 26, 2024 /PRNewswire/ — Freedom Financial Holdings (OTCQX: FDVA), (the “Company” or “Freedom”), the holding company for The Freedom Bank of Virginia (the “Bank”) today announced a net loss of $2,006,393, or -$0.27 per diluted share for the three months ended December…
Allspring Closed-End Funds Declare Monthly Distributions
CHARLOTTE, N.C., Jan. 26, 2024 /PRNewswire/ — The Allspring Income Opportunities Fund (NYSE American: EAD), the Allspring Multi-Sector Income Fund (NYSE American: ERC), and the Allspring Utilities and High Income Fund (NYSE American: ERH) have each announced a distribution. TICKER Fund…
Allspring Closed-End Funds Declare Monthly Distributions
CHARLOTTE, N.C., Jan. 26, 2024 /PRNewswire/ — The Allspring Income Opportunities Fund (NYSE American: EAD), the Allspring Multi-Sector Income Fund (NYSE American: ERC), and the Allspring Utilities and High Income Fund (NYSE American: ERH) have each announced a distribution. TICKER Fund…
Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
NEW YORK, Jan. 26, 2024 /PRNewswire/ — Seelos Therapeutics, Inc. (Nasdaq: SEEL) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders (“CNS”) and rare diseases, today announced that it has entered into…
Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
NEW YORK, Jan. 26, 2024 /PRNewswire/ — Seelos Therapeutics, Inc. (Nasdaq: SEEL) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders (“CNS”) and rare diseases, today announced that it has entered into…
Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2023 Distributions
PASADENA, Calif., Jan. 26, 2024 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced the tax treatment of its year 2023 distributions as described in the chart below. Stockholders are encouraged to consult with their own tax advisors as to their specific tax…
Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2023 Distributions
PASADENA, Calif., Jan. 26, 2024 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced the tax treatment of its year 2023 distributions as described in the chart below. Stockholders are encouraged to consult with their own tax advisors as to their specific tax…
PSEG To Announce Fourth Quarter and Full Year 2023 Financial Results On Feb. 26
NEWARK, N.J., Jan. 26, 2024 /PRNewswire/ — Public Service Enterprise Group Incorporated (PSEG) will host its fourth quarter and full year 2023 earnings call at 11:00 a.m. ET on Monday, Feb. 26, during which management will discuss fourth quarter and full year financial results, financial…
